Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm

OBJECTIVE: To explore the efficacy of botulinum toxin type A (BTX-A) therapy in relieving anxiety and depression in patients with hemifacial spasm (HFS) and benign essential blepharospasm (BEB). PATIENTS AND METHOD: Ninety idiopathic HFS patients and 90 BEB patients were enrolled. The anxiety and de...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Hongjuan, Fan, Shanghua, Luo, Ying, Peng, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304258/
https://www.ncbi.nlm.nih.gov/pubmed/30587995
http://dx.doi.org/10.2147/NDT.S181820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304258/
https://www.ncbi.nlm.nih.gov/pubmed/30587995
http://dx.doi.org/10.2147/NDT.S181820

Ejemplares similares